Literature DB >> 3013270

Human pulmonary alveolar macrophages with smokers' inclusions: their relation to the cessation of cigarette smoking.

R M Agius, A Rutman, R K Knight, P J Cole.   

Abstract

Bronchoalveolar lavage (BAL) was performed in 47 patients (24 smokers, 18 ex-smokers and 5 who never smoked). Cytocentrifuged preparations were stained with May-Grunwald-Giemsa (MGG) and differential counts of pulmonary alveolar macrophages (PAM) with smokers' inclusions were performed. The data supported an exponential reduction in this percentage and indicated that about 3 years elapsed before this percentage approximated to the values in patients who had never smoked. Electron microscopy was performed on eight BALs and the results supported those obtained by light microscopy.

Entities:  

Mesh：

Year:  1986        PMID： 3013270      PMCID： PMC2013024     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


  4 in total

1.  Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers.

Authors:  R R Martin
Journal:  Am Rev Respir Dis       Date:  1973-04

2.  A comparison of alveolar macrophages and pulmonary surfactant(?) obtained from the lungs of human smokers and nonsmokers by endobronchial lavage.

Authors:  S A Pratt; T N Finley; M H Smith; A J Ladman
Journal:  Anat Rec       Date:  1969-04

3.  Bronchoalveolar lavage for the preparation of free lung cells: technique and complications.

Authors:  P Cole; C Turton; H Lanyon; J Collins
Journal:  Br J Dis Chest       Date:  1980-07

4.  Histochemical staining and in vitro spreading of human pulmonary alveolar macrophages: variability with cigarette smoking status.

Authors:  G A Warr; R R Martin
Journal:  J Reticuloendothel Soc       Date:  1978-01
  4 in total
  6 in total

Review 1.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

2.  Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.

Authors:  Liesel D'silva; Nesreen Hassan; Hong-Yu Wang; Melanie Kjarsgaard; Ann Efthimiadis; Frederick E Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

Review 3.  Extracellular superoxide dismutase and risk of COPD.

Authors:  Rebecca E Oberley-Deegan; Elizabeth A Regan; Vuokko L Kinnula; James D Crapo
Journal:  COPD       Date:  2009-08       Impact factor: 2.409

4.  Characterizing the Transport of Aluminum, Silicon, and Titanium-Containing Particles and Nanoparticles in Mainstream Tobacco Smoke.

Authors:  Mark R Fresquez; Clifford H Watson; Liza Valentin-Blasini; R Steven Pappas
Journal:  J Anal Toxicol       Date:  2020-10-12       Impact factor: 3.367

Review 5.  Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.

Authors:  Athol U Wells; Andrew G Nicholson; David M Hansell
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

Review 6.  Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease.

Authors:  Sebastian T Lugg; Aaron Scott; Dhruv Parekh; Babu Naidu; David R Thickett
Journal:  Thorax       Date:  2021-05-13       Impact factor: 9.139
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.